Market Place
Sourcing Support
All News #Library
Biotech
Affinia Therapeutics Advances AFTX-201 To Phase 1/2 Trial
04 Feb 2026 //
BUSINESSWIRE
Affinia Therapeutics Joins Investor Conferences
14 Oct 2025 //
BUSINESSWIRE
Affinia Therapeutics Announces Series C Financing
07 Oct 2025 //
BUSINESSWIRE
Affinia Therapeutics Presents New Data on AFTX-201 Program at ASG
13 May 2025 //
BUSINESSWIRE
Affinia to Present BAG3, BBB AAV, and Tech at ASGCT 2025
28 Apr 2025 //
BUSINESSWIRE
Affinia Therapeutic Appoint Hideo Makimura as Chief Medical Officer
05 Feb 2025 //
PR NEWSWIRE
Affinia Announces BAG3 DCM Candidate, Completes Pre-IND FDA Meeting
09 Jan 2025 //
PR NEWSWIRE
Affinia To Highlight Data On Genetic Cardiomyopathy At ESGCT 2024
22 Oct 2024 //
PR NEWSWIRE
Affinia`s Novel AAV Capsids, Cardiomyopathy/ALS Data At ASGCT
22 Apr 2024 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.